Co-targeting EGFR and SUCLG2 disrupts a nuclear transcriptional program driving neuroendocrine differentiation and TKI resistance in castration-resistant prostate cancer. - Chen WY; Huang KH; Kajla G; Wen YC; Liu MK; Fan YC; Dung PVT; Yeh HL; Chen WH; Jiang KC; Li HR; Chen CS; et al. (Cell communication and signaling : CCS, 2026)